vs
LifeMD, Inc.（LFMD）与Oncology Institute, Inc.（TOI）财务数据对比。点击上方公司名可切换其他公司
Oncology Institute, Inc.的季度营收约是LifeMD, Inc.的20.0倍（$142.0M vs $7.1M）。LifeMD, Inc.净利率更高（282.0% vs -5.3%，领先287.3%）。Oncology Institute, Inc.同比增速更快（41.6% vs 5.0%）。Oncology Institute, Inc.自由现金流更多（$2.2M vs $-3.4M）。过去两年Oncology Institute, Inc.的营收复合增速更高（22.5% vs -60.0%）
SBI人寿保险有限公司是一家印度人寿保险公司，由印度国家银行（SBI）与法国金融机构法国巴黎保险集团合资成立，是印度寿险市场的知名从业机构，为当地民众提供各类人寿保险相关产品与服务。
肿瘤研究所股份有限公司是一家专注于肿瘤诊疗领域的专业医疗企业，提供循证抗癌治疗方案、临床试验参与通道及配套支持护理服务，主要面向美国境内各类癌症患者，协同医疗从业者优化诊疗效果。
LFMD vs TOI — 直观对比
营收规模更大
TOI
是对方的20.0倍
$7.1M
营收增速更快
TOI
高出36.6%
5.0%
净利率更高
LFMD
高出287.3%
-5.3%
自由现金流更多
TOI
多$5.6M
$-3.4M
两年增速更快
TOI
近两年复合增速
-60.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $7.1M | $142.0M |
| 净利润 | $20.0M | $-7.5M |
| 毛利率 | 40.2% | — |
| 营业利润率 | -87.9% | -4.9% |
| 净利率 | 282.0% | -5.3% |
| 营收同比 | 5.0% | 41.6% |
| 净利润同比 | 742.5% | 43.0% |
| 每股收益（稀释后） | — | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFMDTOI
| Q4 25 | $7.1M | $142.0M | ||
| Q3 25 | $60.2M | $136.6M | ||
| Q2 25 | $62.7M | $119.8M | ||
| Q1 25 | $64.1M | $104.4M | ||
| Q4 24 | $6.7M | $100.3M | ||
| Q3 24 | $53.3M | $99.9M | ||
| Q2 24 | $50.7M | $98.6M | ||
| Q1 24 | $44.1M | $94.7M |
净利润LFMDTOI
| Q4 25 | $20.0M | $-7.5M | ||
| Q3 25 | $-3.8M | $-16.5M | ||
| Q2 25 | $-1.6M | $-17.0M | ||
| Q1 25 | $-183.8K | $-19.6M | ||
| Q4 24 | $-3.1M | $-13.2M | ||
| Q3 24 | $-4.7M | $-16.1M | ||
| Q2 24 | $-6.9M | $-15.5M | ||
| Q1 24 | $-6.8M | $-19.9M |
毛利率LFMDTOI
| Q4 25 | 40.2% | — | ||
| Q3 25 | 87.7% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 86.5% | — | ||
| Q4 24 | -0.8% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 90.1% | — | ||
| Q1 24 | 89.6% | — |
营业利润率LFMDTOI
| Q4 25 | -87.9% | -4.9% | ||
| Q3 25 | -3.3% | -5.9% | ||
| Q2 25 | -0.7% | -9.4% | ||
| Q1 25 | 1.5% | -9.5% | ||
| Q4 24 | -58.2% | -11.9% | ||
| Q3 24 | -7.5% | -13.9% | ||
| Q2 24 | -12.4% | -16.6% | ||
| Q1 24 | -14.0% | -19.0% |
净利率LFMDTOI
| Q4 25 | 282.0% | -5.3% | ||
| Q3 25 | -6.3% | -12.1% | ||
| Q2 25 | -2.6% | -14.2% | ||
| Q1 25 | -0.3% | -18.8% | ||
| Q4 24 | -46.1% | -13.1% | ||
| Q3 24 | -8.7% | -16.1% | ||
| Q2 24 | -13.6% | -15.7% | ||
| Q1 24 | -15.3% | -21.0% |
每股收益（稀释后）LFMDTOI
| Q4 25 | — | $-0.04 | ||
| Q3 25 | — | $-0.14 | ||
| Q2 25 | $-0.05 | $-0.15 | ||
| Q1 25 | $-0.02 | $-0.21 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | $-0.13 | $-0.18 | ||
| Q2 24 | — | $-0.17 | ||
| Q1 24 | — | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $23.2M | $-15.7M |
| 总资产 | $70.4M | $164.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LFMDTOI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $36.2M | — | ||
| Q1 25 | $34.4M | — | ||
| Q4 24 | $35.0M | — | ||
| Q3 24 | $37.6M | — | ||
| Q2 24 | $35.7M | $9.9M | ||
| Q1 24 | $35.1M | $29.8M |
总债务LFMDTOI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $15.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LFMDTOI
| Q4 25 | $23.2M | $-15.7M | ||
| Q3 25 | $1.3M | $-12.3M | ||
| Q2 25 | $-1.8M | $-9.0M | ||
| Q1 25 | $-2.3M | $5.1M | ||
| Q4 24 | $-9.1M | $3.6M | ||
| Q3 24 | $-7.7M | $15.5M | ||
| Q2 24 | $-4.2M | $29.2M | ||
| Q1 24 | $-845.3K | $41.3M |
总资产LFMDTOI
| Q4 25 | $70.4M | $164.7M | ||
| Q3 25 | $66.0M | $163.6M | ||
| Q2 25 | $73.6M | $159.8M | ||
| Q1 25 | $73.6M | $164.0M | ||
| Q4 24 | $76.1M | $172.7M | ||
| Q3 24 | $72.6M | $179.2M | ||
| Q2 24 | $63.8M | $179.6M | ||
| Q1 24 | $61.5M | $204.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.3M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $-3.4M | $2.2M |
| 自由现金流率自由现金流/营收 | -48.5% | 1.5% |
| 资本支出强度资本支出/营收 | 2.2% | 0.7% |
| 现金转化率经营现金流/净利润 | -0.16× | — |
| 过去12个月自由现金流最近4个季度 | $6.4M | $-27.8M |
8季度趋势，按日历期对齐
经营现金流LFMDTOI
| Q4 25 | $-3.3M | $3.2M | ||
| Q3 25 | $-147.1K | $-12.6M | ||
| Q2 25 | $8.6M | $-10.2M | ||
| Q1 25 | $3.1M | $-5.0M | ||
| Q4 24 | $1.1M | $4.2M | ||
| Q3 24 | $6.7M | $819.0K | ||
| Q2 24 | $4.5M | $-15.7M | ||
| Q1 24 | $5.2M | $-15.9M |
自由现金流LFMDTOI
| Q4 25 | $-3.4M | $2.2M | ||
| Q3 25 | $-944.4K | $-13.2M | ||
| Q2 25 | $7.8M | $-11.4M | ||
| Q1 25 | $2.9M | $-5.3M | ||
| Q4 24 | $875.4K | $2.4M | ||
| Q3 24 | $6.3M | $417.0K | ||
| Q2 24 | $3.9M | $-17.5M | ||
| Q1 24 | $5.0M | $-16.5M |
自由现金流率LFMDTOI
| Q4 25 | -48.5% | 1.5% | ||
| Q3 25 | -1.6% | -9.7% | ||
| Q2 25 | 12.5% | -9.5% | ||
| Q1 25 | 4.6% | -5.1% | ||
| Q4 24 | 13.0% | 2.4% | ||
| Q3 24 | 11.7% | 0.4% | ||
| Q2 24 | 7.7% | -17.7% | ||
| Q1 24 | 11.4% | -17.4% |
资本支出强度LFMDTOI
| Q4 25 | 2.2% | 0.7% | ||
| Q3 25 | 1.3% | 0.4% | ||
| Q2 25 | 1.3% | 1.0% | ||
| Q1 25 | 0.2% | 0.3% | ||
| Q4 24 | 2.9% | 1.8% | ||
| Q3 24 | 0.8% | 0.4% | ||
| Q2 24 | 1.3% | 1.9% | ||
| Q1 24 | 0.4% | 0.6% |
现金转化率LFMDTOI
| Q4 25 | -0.16× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFMD
暂无分部数据
TOI
| Other | $82.1M | 58% |
| Fee For Service | $36.3M | 26% |
| Capitated Revenue | $23.6M | 17% |
